Our Decentralized Clinical Trials are executed through telemedicine and mobile/local healthcare providers, using procedures that vary from the traditional clinical trial model.

Our studies take advantage of technologies (apps, telemedicine, wearables, sensors, etc.) and engagement systems (i.e. messaging, gamification, data sharing, etc.) to conduct part or all of the study from a location other than a traditional research site (i.e. home, pharmacy, etc.)

Our team supports the strategy, design, vendor selection and application of DCT methodologies and are responsible for coordination and setup of the DCT elements of hybrid or fully virtual trials.

Regulatory authorities require more and more clinical data. Protocols are increasingly complex, and the challenges of recruiting patients and qualified investigators continue to grow. In this climate, our early and careful evaluation of protocol and recruitment plans can help avoid costly missteps.

Our information-driven approach to Site and Patient Access uses unique patient insight data from multiple providers, including medical claims, EMR, social listening and performance data in unique “delivery prescriptions” for each clinical project. When coupled with our Catalyst Site delivery models, this can result in predictable and efficient project delivery.